Stock futures were mostly lower Thursday after the S&P 500 closed just shy of a record high and as excitement around artificial intelligence helped lift the Nasdaq Composite to a gain of 1.3%.These stocks were poised to make moves Thursday:Electronic Arts was tumbling 16% after the maker of video games slashed its fiscal-year bookings guidance because of underperformance in its soccer titles.
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
U.S. stock futures were mixed on Thursday following Wednesday's rally. Futures of benchmark indices were lower except Dow Jones.
GE Aerospace posts strong Q3 results, announces $7B stock buyback; shares soar. American Airlines expects a significant Q4 loss; EA cuts 2025 net bookings guidance.
Donald Trump presidential inauguration, Martin Luther King Jr. Day federal holiday, earnings expected from Netflix, American Express, United Airlines
American Airlines AAL-Q forecast 2025 profit below Wall Street expectations as the carrier braces for higher costs stemming from expensive labour contracts signed last year, sending its shares ...
Sikorsky and GE Aerospace on Jan. 29 announced the first engine runs of T901 Improved Turbine Engines on a UH-60M Black Hawk ahead of a planned first flight later this year. The engine runs, which took place at Sikorsky’s facility in West Palm Beach, Florida, verified system functionality, engine...
A PSA Airlines CRJ-700 and a U.S. Army UH-60L Black Hawk helicopter collided as the regional airliner was about to land at Ronald Reagan National Airport Jan. 29 near Washington, prompting a large-scale emergency response though casualties were unknown as of late evening. The Federal Aviation...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.5glegtPn.js
Emerging as a separate public company following the spinoff of its alternative energy segment GE Vernova GEV in April 2024, GE Aerospace’s GE expansion is very compelling as a provider of jet engines,
Novo Nordisk shares surged on the results of a new obesity-drug study Friday. The Danish pharmaceutical giant behind Ozempic and Wegovy said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.